Ultrastructural features of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in an experimental model of febrile seizures and with the use of topiramate

Folia Neuropathologica

Volumn 47, Issue 3, 2009, Pages 268-277

  Łotowska, Joanna M ^a   Sobaniec Łotowska, Maria E ^a   Sobaniec, Wojciech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Experimental febrile seizures; Hippocampal cortex; Neocortex; Protoplasmic astrocytes; Topiramate; Ultrastructure

Indexed keywords

TOPIRAMATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL CULTURE; CELL POPULATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DEGRADATION; DRUG EFFICACY; ENDOPLASMIC RETICULUM; FEBRILE CONVULSION; HIPPOCAMPUS; MALE; MITOCHONDRION; NEOCORTEX; NEUROPROTECTION; NONHUMAN; PERIKARYON; RAT; TEMPORAL LOBE;

EID: 70350383076     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Akerman S, Goadsby PJ. Topiramate inhibits trigeminovascular activation: an intravital microscopy study. Br J Pharmacol 2005; 146: 7-14.
2. Angehagen M, Hansson E, Rönnbäck L, Ben-Menachem E. Does topiramate (TPM) have protective effects on astroglial cells and neurons in primary cortical cultures? Epilepsia 1998; 39 (Suppl 6): 44.
3. Angehagen M, Ben-Menachem E, Rönnbäck L, Hansson E. Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures. Epilepsy Res 2003; 54: 63-71.
4. Angehagen M, Rönnbäck L, Hansson E, Ben-Menachem E. Topiramete reduces AMP-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem 2005; 94: 1124-1130.
5. Cardile V, Pavone A, Renis M, Maci T, Perciavalle V. Effects of Gabapentin and Topiramate in primary rat astrocyte cultures. Neuroreport 2001; 12: 1705-1708.
6. Dydyk L, Pluta R. Influence of hyperthermia on ultrastructure of the cerebral cortex and subcortical white matter in rabbits. Neuropat Pol 1984; 22: 97-115.
7. Edmonds HL Jr, Jiang YD, Zhang PY, Shank R. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci 2001; 69: 2265-2277.
8. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 2004; 24: 4412-4420.
9. Gibbs JW 3rd, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000; 41 (Suppl 1): S10-S16
10. Groniowski J. Ultrastructural bases of disease. In: Groniowski J, Krus S (eds.). Bases of pathomorphology. PZWL, Warszawa 1991; pp. 34-72.
11. Huang CW, Pai MC, Tsai JJ. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy. Psychiatry Clin Neurosci 2008; 62: 548-553.
12. Kamal A, Notenboom RG, de Graan PN, Ramakers GM. Persistent changes in action potential broadening and the slow afterhyperpolarization in CA1 pyramidal cells after febrile seizures. Eur J Neurosci 2006; 23: 2230-2234.
13. Kang JQ, Shen W, Macdonald RL. Why does fever trigger febrile seizures? GABAA receptor gamma2 subunit mutations associated with idiopathic generalized epilepsies have temperaturedependent trafficking deficiencies. J Neurosci 2006; 26: 2590-2597.
14. Kim DS, Kim JE, Kwak SE, Choi HC, Song HK, Kimg YI, Choi SY, Kang TC. Up-regulated astroglial TWIK-related acid-sensitive K+ channel-1 (TASK-1) in the hippocampus of seizure-sensitive gerbils: a target of anti-epileptic drugs. Brain Res 2007; 1185: 346-358.
15. Knudsen FU. Febrile seizures treatment prognosis. Epilepsia 2000; 41: 2-9.
16. Kramer U, Sagi L, Goldberg-Stern H, Zelnik N, Nissenkorn A, Ben-Zeev B. Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 2009; 50: 1517-1524.
17. Kudin AP, Debska-Vielhaber G, Vierlhaber S, Elger CE, Kunz WS. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 2004; 45: 1478-1487.
18. Lewis DV. Losing neurons: selective vulnerability and mesial temporal sclerosis. Epilepsia 2005; 46 (Suppl 7): 39-44.
19. Lin JJ, Lin KL, Wang HS, Hsia SH, Wu CT. Effect of topiramate, in combination with lidocaine, and phenobarbital, in acute encephalitis with refractory repetitive partial seizures. Brain Dev 2008 (Epub ahead of print).
20. Lotowska JM, Sobaniec-Lotowska ME, Sendrowski K, Sobaniec W, Artemowicz B. Ultrastructure of the blood-brain barrier of the gyrus hippocampal cortex in an experimental model of febrile seizures and with the use of new generation antiepileptic drug - topiramate. Folia Neuropathol 2008; 46: 57-68.
21. Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel JJ, Pedley TA (eds.). Epilepsy: A comprehensive textbook. Philadelphia, Lippincott-Raven 1997; pp. 133-155.
22. Niebauer M, Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 1999; 837: 263-269.
23. Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, Kim IH, Kim H, Eun BL. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 2006; 201: 470-478.
24. Pavone A, Cardile V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia 2003; 44 (Suppl 10): 34-39.
25. Poulsen CF, Schousboe I, Sarp A, White HS, Schousboe A. Effect of topiramate and dBcAMP on expression of the glutamate transporters GLAST and GLT-1 in astrocytes cultured separately, or together with neurons. Neurochem Int 2006; 48: 657-661.
26. Scott RC, King MD, Gadian DG, Neville BG, Connelly A. Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain 2003; 126: 2551-2557.
27. Sendrowski K, Sobaniec W, Sobaniec-Lotowska ME, Artemowicz B. Topiramate as a neuroprotectant in the experimental model of febrile seizures. Adv Med Sci 2007; 52 (Suppl 1): 161-165.
28. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. On overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics and mechanisms of action. Epilepsia 2004; 41 (Suppl 1): S3-S9.
29. Smith-Swintosky VL, Zhao B, Shank RP, Plata-Salaman RP. Topiramate promotes neurite outgrowth and recovery of function after nerve injury. Neuroreport 2001; 12: 1031-1034.
30. Swanson RA, Liu J, Miller JW, Rothstein JD, Farrell K, Stein BA, Longuemare MC. Neuronal regulation of glutamate transporter subtype expressions in astrocytes. J Neurosci 1997; 17: 932-940.
31. Wojtal K, Browicz KK, Blaszczyk B, Czuczwar SJ. Interactions of excitatory amino acids receptor antagonists with antiepileptic drugs in three basis models of experimental epilepsy. Pharmacol Rep 2006; 58: 587-598.